Jiangsu Hengrui Medicine (恒瑞医药) is a leading innovative pharmaceutical company in China with annual sales of 4.55 billion Chinese Yuan in 2011 and is poised to continue its growth in coming years. Under the leadership of successful and experienced scientists and drug discovery veterans returning from US/Europe, its R&D force now has over 800 scientists and has developed the most robust innovative drug discovery pipeline in Chinese pharmaceutical industry. Hengrui’s R&D engine, Shanghai Hengrui (上海恒瑞), is actively recruiting quality scientists to lead/participate in exciting drug discovery efforts in both small and large molecules. Qualified scientists should have a PhD degree with/without postdoc experience in molecular biology/biochemistry or related disciplines with successful track records. Scientists with in vivo animal model, large molecule (protein and/or antibody) experience are highly desirable. The candidates are expected to actively lead/engage in target discovery, in vitro assay and in vivo animal model development and govern drug discovery processes in a team oriented environment. These group leader positions will be located in Shanghai, China with great compensation and relocation packages. Candidates with interest in joining Hengrui Pharmaceutical, please send your letter/resumes to Dr. Guoqing Cao, PhD c***[email protected]